AB STRACT It was investigated whether or not the human blood group isoantibodies A and B could be induced by immunogenic stimuli via natural routes with a kind of antigenic substance to which all humans are commonly exposed, or if the appearance of these antibodies is independent of antigenic stimuli as has long been believed.
AB STRACT It was investigated whether or not the human blood group isoantibodies A and B could be induced by immunogenic stimuli via natural routes with a kind of antigenic substance to which all humans are commonly exposed, or if the appearance of these antibodies is independent of antigenic stimuli as has long been believed.
Escherichia coli O, which possess high human blood group B and faint A activity in vitro, were fed to healthy humans and those with intestinal disorders. 80% of the sick individuals of blood group 0 and A responded with a significant rise of anti-B antibodies which was frequently de novo in infants; significant increase of anti-A isoantibodies among blood group 0 individuals was less frequent. Over one-third of the healthy individuals also had a significant isoantibody increase. Intestinal lesions favor isoantibody stimulation by intestinal bacteria; this view was supported by the study of control infants. Persons of blood group A responded more frequently with anti-B and anti-E. coli 086 antibody production than those of blood group 0. Isoantibody increase was accompanied with antibody rise against E. coli O. Inhalation of E. coli 086 or blood group AH(0)-specific hog mucin also evoked isoantibodies.
The induced isoantibodies were specifically inhibited by small amounts of human blood group substances. E. coli Ow-induced anti-blood group antibodies in germfree chickens and preexisting blood group antibodies in ordinary chickens were neutralized by intravenous injection of E. coli O lipopolysaccharide.
This study demonstrates that human isoantibodies A and B are readily elicited via physiological routes, by INTRODUCTION Two contradictory views on the origin in humans of demonstrable blood group A and B isoantibodies have been advanced. According to the older genetic hypothesis these antibodies are inherited by pairs of linked genes, each representing a blood group antigen and its complementary antibody. The immunogenetic hypothesis, on the other hand, contends that while the ability to manufacture antibodies is inherited, isoantibodies become demonstrable only if the antibody-producing machinery of the host is exposed to exogenous cross-reactive or homologous antigens (cf. [1] [2] [3] . More recent experimental evidence, namely parenteral immunization in man (4, 5) and feeding of fowl with blood group-active substances, including those of microbial origin (6) , strongly supports the immunogenetic hypothesis of isoantibody origin.
Further circumstantial evidence for the immunogenetic origin of isoagglutinins has been adduced by demonstration of the wide distribution of substances with human blood group A, B, and H(O) specificity among enteric bacteria (7) . However, direct proof has so far been lacking of blood group isoagglutinin stimulation in man by microbes or its formation as a result of stimulation via truly physiological routes, namely, the gastrointestinal or respiratory tracts.
The present paper reports the stimulation (frequently de novo) of saline agglutinating and blocking' isoantibodies in infants and the increase of isoantibodies in adults by feeding blood group B-specific bacteria. Increased production of isoantibodies occasionally resulted from inhalation of blood group-active bacteria or hog gastric mucin. Some biological properties of the induced antibodies are described. In vivo neutralization of antihuman blood group antibodies of germfree and ordinary chickens has also been achieved.
METHODS
Subjects. Healthy humans of both sexes and all age groups, infants with mild to severe diarrhea, and adults with ulcerative colitis and cancer of the colon were investigated. The majority of the infants were awaiting placement in foster homes and the blood groups of their mothers were not available. None of the individuals had received a recent blood transfusion or vaccination. Germfree and ordinary male and female White Leghorn chickens raised and maintained under conditions closely similar to those previously reported were used (6) .
Blood group-specific antigens. Human blood group B-specific smooth E. coli O0m B: 7 was the most frequent source of antigen. Immunization of chickens and rabbits with E. coli 086 indicated that these bacteria also possess blood group A specificity (6, 8) and we have found that the in vitro blood group A activity of smooth E. coli 086, as measured with human anti-blood group A sera and A1 or A2 erythrocytes, amounts to 0.2-2.5%, of its blood group B activity.2 The bacteria were grown as previously described on fully defined media devoid of blood group-active substances (9) . Cultures in the logarithmic phase of growth were used in the feeding experiments with live bacteria. Killed E. coli O for feeding or inhalation were obtained from 24-to 48-liter cultures grown for approximately 48 hr at 370C. The bacteria were harvested by centrifugation at 30,000 g, washed with 0.85%o aqueous NaCl, dried in vacuo over KOH in the presence of toluene vapor, and subsequently ground in a mortar to produce a powder. No bacteria could be cultured from this powder on blood agar plates. For injection, blood group-active lipopolysaccharide (L.P.S.) was extracted from E. coli 086 by established procedures and purified as described previously (10) . 10 jig/ml of the powder and 1.2 ,Ag/ml of the lipopolysaccharide completely inhibited four hemagglutinating doses of human anti-blood group B serum under standard conditions (7) . Commercial hog gastric mucin (Wilson & Co., No. 106 465) which possessed high human A and H (O) blood group activity (0.3 ,g/ml inhibited four doses of anti-A serum) was employed in inhalation experiments.
Immunization. (a) Man. Immunization was attempted by feeding and inhalation. In the feeding experiments both healthy and sick individuals ranging in age from less than 1 wk to 70 yr were given killed E. coli 086. All subjects were of blood group A or 0, except two, one of whom had blood group B and the other A2B. For infants the feedings were scheduled to be 500 mg E. coli O8 three times daily 'As blocking antibodies are defined those which did not agglutinate red cells suspended in saline, but which were demonstrable by the anti-human serum test. 2 Springer, G. F., and H. Tegtmeyer. Unpublished observations.
for 7 days and for adults 1-3 g given within 24 hr in 1 g lots. This plan could not be strictly adhered to because some individuals regurgitated the bacterial preparations whereupon the feeding was interrupted for several days. Some adult volunteers received a single dose of 107-1Q8 live, smooth E. coli 086 in 1 oz of milk.
Immunization by nasal inhalation was attempted in adults 19-61 yr old with aerosol sprays from plastic 10-ml squeeze bottles. The spray contained either killed E. coli 0m bacteria in 0.1% final concentration or hog mucin in 1.0%o final concentration in buffered saline (see below) containing 0.05% Zephiran and 1% peppermint spirits. Each bottle delivered about 0.07 ml per squeeze. This volume was applied to each nostril three times daily for 7 days; this schedule amounted to ca. 3 mg of E. coli 086 and ca. 30 mg of hog mucin. 12 males inhaled the E. coli 086 spray; eight of these were of blood group A and four of blood group 0. 12 different males inhaled hog mucin; three of them were of blood group B, the remainder of blood group 0. At least six inhalations per individual were supervised. After the assigned period all subjects returned the spray bottles and the amount of material used was determined from the residue by difference.
In the case of hog mucin 99.65%o of the amount planned was inhaled, with a range from 54 to 143%,; for the E. coli spray the average was 109% with a range from 68 to 153%o.
(b) Chickens. The procedure of bacterial "monocontamination" of germfree chicks has been previously described (6) . In these peroral immunizations, which were also employed in the ordinary chickens, the birds were given once live E. coli 0On in their drinking water. 1-2 months after the feeding of bacteria the chickens were given one intravenous injection of 3 mg/kg of body weight of E. coli 0m L.P.S. dissolved and autoclaved in buffered saline.
Microbiological testing procedures. These have been described earlier for germfree chickens (6) . In man, stool specimens of those given killed E. coli were collected with sterile swabs immediately on defecation within a few hours before the experiments and during the experiments as indicated. Stool specimens from those fed live E. coli were taken 3 days before bacterial feeding, a number of hours before this feeding, and one each 24 hr, 5 days, and 12 days after ingestion of the E. coli. Bacteria were cultured and Gramnegative organisms isolated by standard procedures of clinical bacteriology. 6-11 coli-like cultures per stool specimen were picked at random from blood agar and MacConkey plates and each of these were subcultured as described above under "Blood group-specific antigens." The bacteria were then harvested by centrifugation, boiled for 21 hr in distilled water and their final dry weight adjusted to 0.5-1% and tested for blood group activity (cf. 7).
Blood and saliva samples. Blood was always collected immediately before the first and after the last immunization as indicated in the "Result" section. Venous blood was obtained from the arm and rarely from the heel in humans; the chickens were bled from the main wing vein. Human blood, 2-20 ml per session, and up to 10 ml of chicken blood were collected into sterile tubes (cf. 10). Red cells were separated by centrifugation and the sera frozen in 2-ml lots at -20°C. The scarcity of the sera prevented their physicochemical investigation.
Saliva was collected with cotton swabs and extracted with buffered saline, the eluates were boiled for 10 min and centrifuged. Those supernatants which inhibited hemagglutination (see below) were considered to originate from "secretors."
Erythrocytes. Blood group A1, A2, B, and 0 erythrocytes from adults, stored for less than 14 days in one-third volume anticoagulant acid citrate dextrose solution (2.45% glucose, 2.20%o trisodium citrate, 0.8%o citric acid) at 1-30C were used immediately after three washings with 15-20 volumes of buffered saline. For determination of antibodies directed against E. coli 08 human blood group 0 erythrocytes were sensitized as described earlier (10); the minimal amount of E. coli 0s lipopolysaccharide which afforded maximal agglutination was used for sensitization. Control antisera, absorptions, and elutions. Commercial human hyperimmune anti-A and anti-B sera were used as controls. Absorption of some human sera was done where indicated in the "Results" section sometimes over 1 year after the other experiments. Where possible undiluted sera were used and absorbed with one volume washed, packed erythrocytes as outlined previously (6) . All chicken antisera were absorbed with human blood group 0 erythrocytes before use as in previous experiments (6) . Eluates were obtained by a modified Landsteiner-Miller procedure as described earlier (6 Hemagglutination. All tests were done three or more times. Arithmetic averages were reported. Only titer differences which were fourfold or greater were considered to be significant. Titrations of pre-and all postimmunization sera of a given individual were always done in parallel. The method of titration and interpretation of agglutination using saline agglutinating antibodies has been described previously The tests were read independently by two individuals. One was frequently an observer to whom the nature of the samples was unknown. Each titration included as control a saline suspension of the erythrocytes under study. All activities are given as reciprocal titers in terms of dilution of serum used before addition of red cells (called "titers" throughout); an increase from < 1: 1 to 1: 1 was considered to be twofold. The anti-human serum test was carried out with the following variations from the manufacturer's instructions: serial dilutions with 0.1-ml volumes were made throughout. Incubation of red cells with serum was for 1 hr at 230-250C. The erythrocyte suspension had a concentration of 1%o and one drop of anti-human serum or anti-chicken globulin serum was added after thorough washing. Interpretation of agglutination was by microscope.
Hemagglutination inhibition assays were performed on the sera of individuals fed E. coli Om. at the height of their immune response with human blood group A and B glycoproteins isolated from human ovarian cysts and meconium (9, 11) and with E. coli 0. L.P.S. (10) . These tests were also performed with commercial antisera and with human saliva. The procedure was similar to that described previously (12) but scaled down to 0.02 ml of all reagents. The first tube showing no inhibition was taken as the end point. Each titration series included controls consisting of a serum standard diluted to four to eight minimum hemagglutinating doses, and then titrated in twofold geometrical dilutions, as well as an erythrocyte suspension in saline.
RESULTS
Stimulation of anti-blood group B isoantibodies in humans by feeding of E. coli Os. It was found that humans of all ages and both sexes may form isoantibodies as response to ingesting or inhaling blood group-active E. coli Oss. This response occurred more frequently in persons of blood group A than those of blood group 0 (see "Discussion").
Some of the most striking results of feeding experiments in infants are shown in Table I 64-fold increase of saline agglutinins. All sick children 9 wk and older had a significant titer increase. Blocking antibodies were measured in 10 of these infants and were found to generally parallel the antibody response determined with saline agglutinins. There was de novo isoagglutinin stimulation from < 1 to 16 or 64 in six of the seven diarrheic infants. The single infant who possessed no anti-blood group B antibodies at the end of the experiment was A. J., aged 2 wk at the outset. In six of these children agglutinins were also determined more than 1 month after termination of bacteria feeding. In only one instance was there any further significant increase and only of blocking anti-B isoantibodies but in two cases the isoantibodies had decreased significantly. The anti-B isoagglutinin titers of six of these infants were followed up to 13 months. The titer either remained unchanged or decreased as much as 16-fold. Table I shows, in addition, that healthy infants also may produce blood group anti-B isoantibodies upon being fed E. coli Osw. They had a somewhat lesser response; four of seven infants had a significant increase of saline agglutinins. Blocking antibodies were determined in five of these healthy infants; R. B. and T. P. showed a 16-fold titer increase.
The average titer increase of those 13 diarrheic infants who responded to E. coli Os with significant anti-blood group B antibody production was 42-fold for saline agglutinins and 55-fold for blocking anti-B antibodies (determined in only eight of the responding children). Comparative figures for the healthy infants fed E. coli Om were a 14-fold increase of saline agglutinins and a 16-fold rise of blocking antibodies.
14 adults were also fed E. coli Gas. The most pertinent data are depicted in Table II Table II) , blood group A2B, was fed 2 g of killed E. coli 086; he did not produce any kind of anti-B or anti-A antibodies during the 10 day observation following the feeding.
Specific in vitro hemagglutination inhibition. It was attempted to inhibit E. coli Ome-stimulated anti-A and anti-B blood group isoagglutinins. Table IV shows the results obtained with sera of five individuals of blood group 0 and three of blood group A. E. O., M. L., and C. L. were from adults, the remainder from children (see Tables I and II) . Small amounts of homologous human blood group substances completely neutralized the agglutinating ability of these sera; similarly small quantities of blood group B-specific E. coli 0" L.P.S. neutralized Tables I and II) and those of the single child of blood group B (see above) were absorbed with blood group A, and with B erythrocytes. The results are depicted in Table V (Table I) were obtained at the beginning of the experiment; blood group B-active bacteria were found in five of these but significant blood group B isoagglutinin stimulation was noted in only two (G. A.; G. B.).
In addition, in the stools of four sick infants in whom no blood group B-active bacteria were found, bacteria with faint in vitro blood group A activity were detected. These infants, J. N.; C. J.; D. T.; and V. R., were all blood group A,, Rh positive. Preingestion stools of four healthy E. coli Oem-fed infants (Table I) were also investigated. Bacteria with weak blood group A activity only were found in two of them (T. P. and B. T.). No significant change in anti-A titers of any of these infants was observed. The stools of six adults (Table II) (G, Rh positive), had an acute upper respiratory infection. Only this latter infant showed an increase in isoantibodies, which was -confined to a fourfold rise of anti-A as well as anti-E. coli Gee saline agglutinins.
In vivo neutralization of anti-human blood group A and B antibodies in chickens. Anti-human blood group agglutinins can be stimulated in chickens and rabbits with blood group-specific microbes (6, 13). We have now attempted to neutralize in vivo the blood group antibodies of three germfree and two ordinary chickens, 3-4 months old, that had been fed live E. coli OG approximately 2 months after hatching and who had formed optimal anti-blood group B titers. Just before injection the germfree chicken, Nos. 7391, 7392, and 7393, had anti-B agglutinin titers of 512-2048, anti-A titers of 64-256, and blocking antibody titers of 256-512. The agglutinin titers of the two ordinary chickens fed E. coli Gee Neutralization of anti-B agglutinins was from 75 to 92% 20-60 min after injection and that of anti-A agglutinins was 0 and 50% in the two birds who possessed these antibodies at the beginning of the experiment.
DISCUSSION
Human isoantibodies A and B have long been considered to be a prototype of inherited, natural antibodies which arise independent of influences from the environment (14-17), i.e., they are demonstrable without prior immunogenic stimulation. It is not only of theoretical but also of immense practical importance if antibodies indeed could be produced without exogenous stimuli. Based on his theory of the genetic origin of antibodies Hirszfeld hoped ". . . to decipher the epidemiological tale of woe of mankind by the presence of some normal antibodies . . ." as well as for ". . . the possibility of breeding immune animal races with powerful production of normal antibodies . . ." (16, 17) . However, while there is agreement that the ability to manufacture antibodies and the way of a particular immune response are inherited, specific antibodies are not generally known to be present without an antigenic stimulus.
Over the years, strong circumstantial evidence has accumulated implicating the environment as the cause of human isoantibodies A and B. This evidence is based first, on the wide distribution of blood group ABH(O)-specific antigens throughout the animal (1, 2, 11) and plant kingdoms (9, 7) and their resulting ubiquitous occurrence in diet (6) as well as dust (18), and secondly, on the failure to differentiate the so-called natural and immune isoantibodies by their biological or chemical properties (1, (4) (5) (6) . Thirdly, some healthy monozygotic human twins and triplets showed titer differences of > 75% for anti-A, and of > 90% for anti-B isoagglutinins (19, 20) . Consequently, a number of investigators believed isoantibodies, like other antibodies, to be the result of exogenous immunogenic stimulation provided largely by cross-reacting antigens (e.g. 21, 1, 2). Investigations into the origin of anti-microbial antibodies in animals also failed to support the view that natural antibodies occur (cf. 22).
The finding of a large number of Gram-negative blood group-active bacteria, including many different genera of Enterobacteriaceae (cf. 9, 7, 23), made it realistic to consider their role as important causative agents of isoantibody stimulation. Also, our previous studies on ordinary and germfree chickens had established that their regularly occurring anti-human blood group B agglutinins are the result of exogenous immunogenic stimuli and that they are not inherited as had been believed (24, 25) .
Based on these findings Kdrner, Maassen, and Pettenkofer investigated possible correlations between intestinal flora and blood group isoagglutinin titers in infants of blood groups A and 0 (26) . In general they found a higher isoagglutinin titer in those infants who had an intestinal flora in which E. coli strains predominated, as compared to those whose flora consisted mainly of Lactobacillus bifidus. Blood group ABH(O)-active substances have not been found in L. bifidus (9, 26) but are common in E. coli strains (7) (8) (9) 23) .
The work reported in this paper was designed to furnish direct evidence either for or against the role of antigenic agents in the origination of blood group antibodies. Antigens were chosen like those to which humans are exposed throughout life and they were applied via the same routes by which they would enter the host under physiological conditions, namely the gastrointestinal tract and the respiratory system. The results clearly show that both saline agglutinins and blocking A and B isoantibodies can be stimulated by blood group-active E. coli and in infants, including those less than 1 month old, they may be even evoked de novo (Tables I and II Intestinal damage had a more pronounced effect on the isoantibodies of infants than those of adults. However, the initial titer of the two acutely sick adults (E. 0. and M. L.) was as high as the highest ever reached by the majority of the infants. Maximal rise in blood group antibodies after the feeding of E. coli 0m occurred in less than 8 days in adults and in less than 3 weeks in infants. Feeding E. coli Om. to adults appeared to effect mainly a booster reaction, as is also made likely by the proportionally much larger increase of blocking antibodies. The ratio of increase of blocking to saline agglutinating anti-B antibodies for sick and healthy infants was 1.3:1 and 1.1: 1 but 5.4:1 and 4.4:1 for the sick and healthy adults. In most instances there was a response of either both kinds of antibody or neither; exceptions were two infants, A. N. and B. T. (Table I) who showed a saline agglutinin increase only. By the technique employed, an increase in blocking antibodies was demonstrable only if their postimmunization titer was higher than that of the saline agglutinins.
The isoantibody increase was closely similar among the adults of both sexes. A comparison of the response to E. coli O. between male and female infants could not be made since of the seven female infants listed in Table I only two were over 3 wk old at the beginning of the experiment while 13 males were more than 3 wk old.
In spite of the faint in vitro blood group A activity of the E. coli that was administered the extent of the blood group A antibody rise of the three blood group 0 infants was comparable to their increase of anti-B antibodies. The rise of anti-A titers in infants was from low levels throughout, and infants were the only ones, with the exception of D. A. (Table III) , to show a fourfold or greater increase of these antibodies. In contrast to the single significant anti-A response among the adults fed E. coli 08, three of the four healthy blood group 0 individuals who inhaled it (K. B.; Ral. R.; and W. S.) responded with a significant blocking anti-blood group A antibody increase; they also showed a rise of anti-B antibodies, but that of Ral. R. was not significant. Anti-blood group B responses resulting from the inhalation of E. coli Om bacteria or hog gastric mucin were slightly less frequent and the titer increases of those responding were lower than those obtained in healthy adults after ingestion of the antigens. While unknown factors are likely to play a role in these different responses quantitative aspects of the experiments are also likely to be involved. Peroral immunizations with dead bacteria were with 1-10 g (i.e. about 3 X 1012 to 3 X 1013 killed E. coli), while the total amount inhaled was never greater than 3 mg (ca. 1 X 10°bacteria). On the other hand, the weight of the live bacteria consumed by a volunteer was around 10 ug (ca. 3 X 107 bacteria) but as stool cultures indicated the bacteria persisted up to 12 days.
The specificity of the stimulated isoagglutinins is attested to by their inhibition with small amounts of the corresponding blood group-specific antigens of human origin and by the failure of much larger amounts of blood group antigens of a different specificity to accomplish this (see Table IV ).
The isoantibodies reacting with A and B erythrocytes were stimulated by a bacterium which in vitro possesses high blood group B and low A activity. The question arose if the antibodies evoked in blood group 0 persons (Table II) and which reacted with A, and A2 erythrocytes were strictly anti-A-specific or if they were, at least in part, of the cross-reacting kind frequently observed in individuals of blood group 0 (27) (28) (29) . We found that the majority of isoantibodies stimulated by E. coli 0. were of the homologous rather than the crossreacting kind. Previously such cross-reacting antibodies apparently have been studied only in adults. It is, therefore, not possible to state whether or not the lack of stimulation of these antibodies in children is peculiar to E. coli Os.
Experiments with chickens had shown that feeding of blood group B-and A-specific E. coli On does not lead in some mysterious way to unspecific stimulation of antiblood group antibodies since feeding of blood groupinactive E. coli did not evoke antibodies against human blood group antigens (6) . It is in accord with these findings that titer increases or their lack against E. coli On L.P.S.-coated human blood group 0 erythrocytes went hand in hand with change in blood group antibody concentration. The antibodies reacting with the L.P.S. were also directed against other determinant groups of E. coli O. besides those carrying blood group specificity. Thus, absorption with blood group B erythrocytes led to only a small reduction of the antibody titers against E. coli On in all 15 postimmunization sera tested. The significance of this antibody reduction, however, was proven in all instances by elution, with the Landsteiner-Miller technique, of specific anti-blood group B antibodies from the B erythrocytes used for the absorptions. All but one person (B. T.) had antibodies reacting with E. coli O. also in their pre-immunization sera and a similar proportion of these could be absorbed and eluted.
While blood group B erythrocytes removed only a fraction of the antibodies directed against E. coli 0n, > 90% removal of anti-B antibodies stimulated by ingestion of E. coli 0. was achieved by one absorption with E. coli 0. L.P.S.-coated blood group 0 erythrocytes. These coated cells also removed preexisting anti-B antibodies but to a somewhat lesser extent; this illustrates the complex nature of human blood group B antigens and the heterogeneity of the corresponding antibodies (cf. 27).
A comparison of the anti-B antibody rise of infants and adults, healthy as well as sick, in relation to their blood groups showed no influence of Rh type or secretor status but surprisingly, a remarkable difference was found in response of individuals of blood group A and 0. 12 of 14 persons of blood group A responded signifiBlood Group Isoantibody Stimulation by Microbes cantly but only 11 of 23 of blood group 0; the average increase of saline and blocking antibodies among the responders was similar for individuals of blood group A and 0. The findings on antibody increase against E. coli 0m were analogous. 7 of 10 individuals of blood group A responded with a significant rise but only 5 of 12 of blood group 0 showed such an increase; in addition the average titer increase of group A individuals was nearly three times higher. This startling difference in response of isoantibodies and antibodies directed against E. coli Om may possibly be due to a more efficient early elimination of the E. coli 08 antigens by antibodies of persons of blood group 0. Such a hypothesis finds support in the findings of Dr. R. R. Race, F.R.S., (personal communication and reference 30) that only persons of blood group A with severe lesions of their body surfaces may acquire blood group B-like antigens on their erythrocytes (cf. 10).
Any evaluation of the highly significant responses by the infants receiving E coli 08 must consider preexisting blood group-specific bacteria. The necessity of this consideration is illustrated by the significant, apparently microbe-induced rise, during the observation period, in isoantibodies against blood group A, A2, and B erythrocytes in two of the seven infants who served as controls and were not fed E. coli Os. Interestingly, four of the five diarrheic infants in whom blood group A-active bacteria were found were of blood group A, i.e., they did not possess anti-blood group A antibodies.
The failure to demonstrate blood group-active bacteria in a stool does not necessarily prove their absence. However, the examination of the cases investigated was quite thorough (see Methods). Furthermore, while blood group-specific bacteria were found frequently, those with blood group activity amounting to as much as 25 -100% of that of the E. coli Om B: 7 strain were found only once in this study. Similarly, we noted earlier that among about 300 strains of Gram-negative bacteria which were in part selected, highly active bacteria amounted to no more than 20% of all blood group-active bacteria isolated (7) .
The in vivo neutralization of anti-blood group and anti-E. coli antibodies in germfree and ordinary chickens was remarkably complete in those birds who survived the injection. That the birds which died had a lesser neutralization of their antibodies than those who survived tempts one to ascribe a protective function to these or concomitantly removed antibodies (cf. 31, 32).
However, the presented experiments do not permit a conclusion.
The studies presented here give direct evidence in favor of the necessity of immunogenic stimulation of the genetically determined antibody-producing machinery in order to obtain the human isoantibodies anti-A and anti-B. Yet, even the direct proof of the immunogenic origin of the blood group anti-A and anti-B antibodies in man furnished in this investigation and earlier in germfree animals (6) does not exclude the possibility that some natural antibodies, including isoantibodies, may be the result of physiological maturation of an organism and possess a fortuitous complementarity to certain antigenic determinants (cf. 16, 17, 33) . However, while our results do not vitiate such a possibility, they in no way favor it.
